- $954.41m
- $1.20bn
- $821.75m
Annual income statement for HMH Holding, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 677 | 785 | 843 | 822 |
| Cost of Revenue | ||||
| Gross Profit | 186 | 210 | 272 | 246 |
| Selling / General / Administrative Expenses | ||||
| Research And Development | ||||
| Unusual Expense / Income | ||||
| Total Operating Expenses | 657 | 707 | 725 | 714 |
| Operating Profit | 20.3 | 78 | 119 | 108 |
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | -17.9 | 32.8 | 76.5 | 72.6 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -26.6 | 17.4 | 52 | 46.1 |
| Minority Interest | ||||
| Net Income Before Extraordinary Items | ||||
| Net Income | -26.6 | 17.4 | 51.2 | 45.5 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -26.6 | 17.4 | 51.2 | 45.5 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -1.56 | 1.75 | 4.85 | 4.6 |